Hematology/Oncology News

PROVIDENCE, Rhode Island — Misinformation about cancer is prevalent on social media, spanning across platforms and malignancy types, according to a presenter at the COSMO Meeting.

Cemiplimab provided clinically meaningful responses for patients with metastatic and locally advanced cutaneous squamous cell carcinoma, according to a study.

CHICAGO — The way that clinicians are taught to deal with feelings in medicine is complex, according to Jessi Gold, MD, MS.

Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.

Manuka honey may represent an alternative natural approach to reducing tumor growth in breast cancer, according to research conducted at UCLA Health Jonsson Comprehensive Cancer Center.

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more.

PROVIDENCE, Rhode Island — Physicians and other health care professionals can utilize social media to support diversity, equity and inclusion in cancer care, according to a presenter at the COSMO Meeting.

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.